Neuroone Medical Technologies (NMTC) Inventory Average (2021 - 2026)

Neuroone Medical Technologies has disclosed Inventory Average across 6 years of filings, most recently posting $1.6 million for Q1 2026.

• Quarterly Inventory Average rose 7.69% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 7.69% YoY) and the FY2025 annual result came in at $1.6 million, up 19.21% from the prior year.
• Inventory Average retreated to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $1.7 million in Q4 2023 and bottomed at $225509.0 in Q1 2022.
• The 5-year median for Inventory Average is $1.2 million (2024), against an average of $1.1 million.
• Year-over-year, Inventory Average surged 670.14% in 2022 and sank 47.2% in 2024.
• Neuroone Medical Technologies' Inventory Average stood at $804046.0 in 2022, then surged by 107.41% to $1.7 million in 2023, then decreased by 15.81% to $1.4 million in 2024, then grew by 15.37% to $1.6 million in 2025, then declined by 3.93% to $1.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $1.6 million, $1.6 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.